RespireRx Pharmaceuticals
NJ - Glen RockPharmaceutical
Focus: RespireRx is a neurology-focused pharmaceutical company founded in 2016, specializing in brain-related breathing disorders with a pipeline of CNS and respiratory programs. The company operates as a private entity based in Glen Rock, NJ with early-to-mid stage clinical programs.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About RespireRx Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow RespireRx Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CX1739 - 300 mg
Opiate Induced Respiratory DepressionClinical Trials (1)
NCT02735629Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
Phase 2Help build intelligence for RespireRx Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.